This page shows the latest CROs news and features for those working in and with pharma, biotech and healthcare.
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
More from news
Approximately 40 fully matching, plus 143 partially matching documents found.
There are a number of adaptations that CROs and the wider healthcare industry must make to deliver on the promise of personalised medicines. ... This means that CROs need more sophisticated networks with volunteers, patient groups and the NHS in order to
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
Payments between drug sponsors, CROs and investigator sites are often a confusing process rife with delays.
Leading CROs have established dedicated Japanese patient recruitment and clinical teams in the capital to deliver these trials. ... UK CROs have a unique set of resources and expertise that support pharmaceutical companies in meeting the needs of the
CROs and trial design • Early access and regulation • Value demonstration • Strategic communications.
More from intelligence
Approximately 0 fully matching, plus 34 partially matching documents found.
Representing over 300 CROs across Europe, Dr Dehlinger-Kremer will be responsible for developing the foundation's educational activities and overseeing its plans for expansion.
She has previously held director-level roles at US biotechs NovusLife and Cote Orphan, and US CROs Toxikon Corporation and XenoTech.
Dr McCall has nearly 25 years of experience in the pharmaceutical industry and has held senior leadership and advisory positions at CROs, private equity firms and non-profit organisations.
He joins from Veracity Logic. International contract research organisation CROS NT has appointed Mark Paul as senior vice president of its US operations. ... Andrew MacGarvey, CEO of CROS NT, added: “I am delighted to welcome Mark to our company.
Commenting on Dowden's appointment, Taricco said: “Sue's proven track record working with sponsors and CROs gives PRC a unique advantage for customer satisfaction, quality assurance and successful trial management.”.
More from appointments
Approximately 10 fully matching, plus 7 partially matching documents found.
Founded in 2010, Innovative Trials is a UK-based company that works with some of the biggest pharmaceutical companies and Clinical Research Organisations (CROs) globally to help them reach their patient
and internationally, to help pharmaceutical companies and Clinical Research Organisations (CROs) bring new medicines to market. ... Founded in 2010, Innovative Trials works with some of the biggest pharmaceutical companies and CROs globally to help them
Innovative Trials has experience in 25 therapeutic areas and 90+ conditions working with some of the biggest global pharmaceuticals, Clinical Research Organisations (CROs) and biotech companies.
COUCH Health works globally with pharma, biopharma, medical device companies and CROs, providing insights, patient recruitment, patient retention, and investigator site support. ... Through our work with pharma, biopharma, medical device companies and
Through our work with pharma, biopharma, medical device companies and CROs, COUCH Health delivers a patient-first approach through patient insights, patient recruitment, patient retention, and investigator site support.
More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...